LifeWatch AG
| LifeWatch AG | |
|---|---|
| legal form | Corporation |
| ISIN | CH0012815459 |
| founding | 1968 |
| Seat | Zug , Switzerland |
| management | Patrick Schildknecht ( Board of Directors (Switzerland) ), Stephan Rietiker ( CEO ) |
| Number of employees | 612 (2015) |
| sales | 106.63 million USD (2015) |
| Branch | Medical technology |
| Website | www.lifewatch.com |
The LifeWatch AG , headquartered in train is an international provider of telemedicine systems and monitoring services for patients with heart disease and sleep disorders. The company, headquartered in Switzerland, is today worldwide u. a. active in the United States, Switzerland, Macedonia, India, Japan and Israel.
The group of companies employs 544 people and had sales of 91 million US dollars in 2013. LifeWatch is on the Swiss Exchange SWX Swiss Exchange listed .
history
The company was founded in 1986 under the name Card Guard Scientific Survival Ltd. founded as a private stock corporation. Operations began in 1990.
In 1997 the company expanded into the United States and Japan. In 1999, the company went public on the SWX Swiss Exchange. The following year, Instromedix , a division of Alaris Medical Systems Inc. , a provider of telemedicine systems in the USA, took over. In the same year LifeWatch Inc. , a US provider of cardiac event monitoring, pacemaker and Holter services was acquired.
In 2001 the head office was relocated to Neuhausen am Rheinfall, Switzerland, directly near Schaffhausen . At the same time, Quality Diagnostic Services (QDS) , a US provider of cardiac event monitoring, was acquired and merged with LifeWatch.
In 2004 the company signed a multi-year strategic alliance with Samsung Electronics . The agreement provides that Card Guard will develop and manufacture various medical software applications and devices and sell them to Samsung Electronics. At the same time, LifeWatch entered into an exclusive contract with Guidant Corporation to provide various monitoring services for cardiac patients who have been implanted with Guidant ICD defibrillators .
On May 25, 2009, the General Assembly decided to rename the company LifeWatch AG in order to improve communication on the important financial and health markets in the USA and in Europe and to improve the importance of the business with monitoring services for chronically ill patients To express.
In 2010, the company launched NiteWatch, a sleep analysis of patients with suspected obstructive sleep apnea syndrome .